High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapy. (Q54528025)
Jump to navigation
Jump to search
scientific article published in December 1981
Language | Label | Description | Also known as |
---|---|---|---|
English | High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapy. |
scientific article published in December 1981 |
Statements
High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapy. (English)
Franceschi S
1 reference
Mangioni C
1 December 1981
12
3
314-318